AP3S1 and esophageal cancer: Although the consequences of the AP3S1 P158L recurrent mutation in SNSCC are not well understood, recent studies have linked AP3S1 as a driver mutation in esophageal cancer as well as a potential pan-cancer oncogene through facilitation of an immunosuppressive tumor immune microenvironment27,28.